The global market for eClinical solutions, which streamline clinical trials, is projected to expand rapidly, reaching $21.9 billion by 2030, growing at an 11.8% annual rate from 2023. Several factors drive this growth:

•Increased Clinical Trials: The growing number of clinical trials is fueling demand for eClinical solutions.

•Data Quality Focus: These solutions enhance data accuracy and efficiency in clinical trials.

•Government Initiatives: Government funding supports innovation in eClinical solutions.

•EHR Adoption: The transition to electronic health records (EHRs) boosts the need for integrated clinical trial solutions.

Government initiatives and evolving regulations support EHR adoption, driving healthcare providers to implement advanced eClinical solutions. The increasing use of healthcare IT solutions by life sciences organizations and private investments in new eClinical solutions with enhanced capabilities also drive market growth.

These solutions provide valuable benefits for healthcare firms:

•Streamlined Clinical Trials: They optimize clinical trial management and operations.

•Enhanced Patient Data Management: They enable secure and efficient handling of patient data.

Key Insights

• The eClinical solutions market is estimated at $10.0 billion in 2023.

• It is expected to reach $21.9 billion by 2030, growing at a CAGR of 11.8%.

• Key factors driving market growth include increasing clinical trials, data quality focus, government initiatives, and EHR adoption.

Source link: http://www.businesswire.com/news/home/20240812863556/en/eClinical-Solutions-Strategic-Business-Report-2024-Market-to-Grow-by-11.9-Billion-by-2030—Rise-in-Clinical-Trials-Powers-Growth-Rise-in-Pharmaceutical-Sales-to-Drive-Demand—ResearchAndMarkets.com

+ posts

Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.